Amerise Biosciences
Ticker > Company >

Amerise Biosciences share price

Amerise Biosciences Ltd.

BSE: 531681 SECTOR: Finance - Investment  12k   11   1

0.79
-0.03 (-3.66%)
BSE: Today, 09:53 AM

Price Summary

Today's High

₹ 0.84

Today's Low

₹ 0.79

52 Week High

₹ 1.45

52 Week Low

₹ 0.55

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 5.22 Cr.

Advances

₹ 0 Cr.

No. of Shares

6.61 Cr.

P/E

0

P/B

0.99

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  0.8

Operating Revenue

₹ 0 Cr.

Net Profit

₹ -0.15 Cr.

Promoter Holding

0 %

EPS (TTM)

₹  -0.01

Sales Growth

0

ROE

-2.68 %

ROCE

-2.65%

Profit Growth

-22.88 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Income Growth

1 YearNA
3 YearNA
5 Year-100%

Profit Growth

1 Year-22.88%
3 Year16.14%
5 Year-304.23%

ROE%

1 Year-2.68%
3 Year1.81%
5 Year-0.74%

ROCE %

1 Year-2.65%
3 Year1.81%
5 Year-0.74%

ROA%

-2.6475

PEG Ratio

2.94

PAT Margin (%)

0

EPS Growth(%)

NA

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 0.00 0.00
Dec 2024 0.00 0.00
Sep 2024 0.00 0.00
Jun 2024 0.00 0.00
Mar 2024 0.00 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company is trading at 0.8114 times the book value

 Limitations

  • Promoters shareholding is low at 0%.
  • Company has a poor Return on Equity (ROE) track record of 1.80815341298943%.
  • The company a poor ROCE track record of 1.8050845087153% since last 3 years.
  • The company has delivered poor profit growth of 0% over past 3 years

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
Operating Revenue 0 0.04 0 0 0
Other Income 0 0 0 0 0
Interest Expended 0 0 0 0 0
Operating Expenses 0.06 0.02 0.05 0.03 0.02
Total Provisions 0 0 0 0 0
Depreciation 0 0 0 0 0
Profit Before Tax -0.06 0.02 -0.05 -0.03 -0.02
Tax 0 0 0 0 0
Net Profit -0.06 0.02 -0.05 -0.03 -0.02
Adjusted EPS (RS) -0.01 0 -0.01 -0.01 0

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Operating Income 0 0 9.01 0 0
Other Income 0 0 0.57 0.01 0.04
Interest 0 0 0 0 0
Operating Expenses 0.15 0.11 9.03 0.13 0.16
Total Provisions 0 0.23 0 0 0.02
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.15 -0.34 0.55 -0.12 -0.15
Tax 0 0 0 0 0
Profit After Tax -0.15 -0.34 0.55 -0.12 -0.15
Adjusted EPS (Rs.) -0.02 -0.05 0.08 -0.02 -0.02

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 6.61 6.61 6.61 6.61 6.61
Total Reserves -1.18 -1.52 -0.97 -1.09 -1.23
Borrowings 0 0 0.08 0.09 0
Other N/C liabilities 0 0 0 0 0
Current liabilities 0.6 0.54 6.27 0.04 0.02
Total Liabilities 6.02 5.63 11.99 5.65 5.39
Assets
Loans 0 0 0 0 0
Net Block 0 0 0 0 0
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 5.37 3.04 4.69 4.57 2.27
Other Loans 0.63 2.57 1.07 1.07 3.1
Other N/C Assets 0 0 0 0 0
Current Assets 0.03 0.02 6.23 0.01 0.02
Total Assets 6.02 5.63 11.99 5.65 5.39
* Other Non-current Liabilities include Net deferred Liabilities

Corporate Actions

Investors Details

 No Promoters Data available for this company.
Report us
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 100.00 100.00 100.00 100.00 100.00
amrapali fincap limited 2.82 2.82 2.82 2.82 2.82
amrapali industries limit... 4.40 4.40 4.40 4.40 4.40
compact fashions private ... 1.93 1.93 1.93 1.93 1.93
destiny procon private li... 1.85 1.85 1.85 1.85 1.85
dristi fashions pvt ltd ... 4.09 4.09 4.09 4.09 4.09
jagkarta agencies private... 4.11 4.11 4.11 4.11 4.11
kamna coal pvt. ltd. 3.08 3.08 3.08 3.08 3.08
mahboob ghulamhusain gaur... - - - 1.41 1.41
rubeena mahboob gauri 1.73 1.73 1.73 1.73 1.73
twist barter private limi... 4.09 4.09 4.09 4.09 4.09

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Amerise Biosciences - Quaterly Results 3 Feb, 6:12 PM Amerise Biosciences - Quaterly Results 3 Feb, 6:12 PM Amerise Biosciences - Quaterly Results 3 Feb, 6:12 PM Amerise Biosciences - Quaterly Results 22 Oct, 12:00 PM Amerise Biosciences - Quaterly Results 22 Oct, 12:00 PM Amerise Biosciences - Quaterly Results 6 Aug, 2:29 PM Amerise Biosciences - Quaterly Results 6 Aug, 2:29 PM Amerise Biosciences - Quaterly Results 6 Aug, 2:29 PM Amerise Biosciences - Quaterly Results 23 May, 4:15 PM Amerise Biosciences - Quaterly Results 23 May, 4:15 PM Amerise Biosciences - Quaterly Results 23 May, 4:15 PM Amerise Biosciences informs about un-audited financial results 22 Jan, 1:05 PM Amerise Biosciences - Quaterly Results 22 Jan, 12:37 PM Amerise Biosciences - Quaterly Results 22 Jan, 12:37 PM Amerise Biosciences - Quaterly Results 22 Jan, 12:37 PM Amerise Biosciences - Quaterly Results 7 Nov, 4:54 PM Amerise Biosciences - Quaterly Results 8 Aug, 4:34 PM Amerise Biosciences - Quaterly Results 8 Aug, 4:34 PM Amerise Biosciences - Quaterly Results 8 Aug, 4:34 PM Amerise Biosciences - Quaterly Results 4 May, 4:25 PM Amerise Biosciences - Quaterly Results 4 May, 4:25 PM Amerise Biosciences - Quaterly Results 4 May, 4:25 PM Amerise Biosciences - Quaterly Results 25 Jan, 4:06 PM Amerise Biosciences - Quaterly Results 25 Jan, 4:06 PM Amerise Biosciences - Quaterly Results 25 Jan, 4:06 PM Amerise Biosciences - Quaterly Results 8 Aug, 1:36 PM Amerise Biosciences - Quaterly Results 8 Aug, 1:36 PM Amerise Biosciences - Quaterly Results 8 Aug, 1:36 PM Amerise Biosciences informs about certificate 4 Apr, 4:53 PM Amradeep Industries informs about disclosure 15 Jan, 9:53 AM Amradeep Industries informs about outcome of AGM 18 Sep, 11:57 AM Amradeep Industries informs about certificate 7 Jul, 3:24 PM Amradeep Industries informs about change in directorate 9 Jun, 4:53 PM Amradeep Industries informs about confirmation certificate 5 Jan, 3:03 PM Amradeep Industries informs about voting results of AGM 19 Sep, 2:27 PM Amradeep Industries informs about outcome of AGM 19 Sep, 12:16 PM Amradeep Industries informs about change in address of RTA 1 Sep, 2:49 PM Amradeep Industries submits certificate 21 May, 2:19 PM

Amerise Biosciences Stock Price Analysis and Quick Research Report. Is Amerise Biosciences an attractive stock to invest in?

Around 2% of India's total population invests in financial assets. The penetration of the mutual fund industry in India is close to 7% (Based on the number of PAN cardholders). This under penetration of the mutual fund industry offers a huge opportunity for the industry to grow.

Migration to financial savings, wider distribution and sustainable performance are expected to enable growth in the industry. Also, increasing financial literacy among investors, digitization and the number of mediums available tend to attract more investors to invest in the financial markets.

Amerise Biosciences stock price today is Rs 0.79. To understand the functions of the Amerise Biosciences better, you must go through the following points:

Key Financials –

  • Profitability: Profit margin (PAT margin) of the company shows how well a company controls its cost. It is one of the important indicators to show the financial health of the company. Net profit of Amerise Biosciences is Rs -0.1461 Cr and the compounded growth of profit in the past 3 years is 16.1415014085646 %. The PAT margin of Amerise Biosciences is 0 %.

  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Amerise Biosciences , the EPS declined by -22.7778 % YOY. 

 Financial Ratios –

  •  Return on Equity (ROE): Amerise Biosciences has a poor ROE track record. The ROE of Amerise Biosciences is at -2.6821 % for the latest year.

  • P/E Ratio: Relative valuation metrics like the P/E ratio can be used to see if the stock of Amerise Biosciences is worth at the current levels at Rs 0.79. Amerise Biosciences is trading at a current P/E ratio of 0 and the average historical P/E for the last 5 years was 3.27316486161252.

  • P/B ratio can be one of the best metrics to value such companies. Currently, Amerise Biosciences is trading at a P/B of 1.0268 . The average historical P/B for the last 5 years was 1.27650950916811. This can be compared with the Market price per share in order to know if the stock is undervalued or overvalued.

  • Share Price: - The current share price of Amerise Biosciences is Rs 0.79. One can use valuation calculators of ticker to know if Amerise Biosciences share price is undervalued or overvalued.

Last Updated on:
Brief about Amerise Biosciences
X